The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Farzaneh-Far et al., N Engl J Med 354(22):2376-2381 June 1, 2006.

Correspondence
PreviousPrevious
Volume 355:851-852 August 24, 2006 Number 8
NextNext

Thinking Outside the Box

 

This Article
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Farzaneh-Far, R.
-PubMed Citation
To the Editor: Farzaneh-Far et al. (June 1 issue)1 describe a case of massive pulmonary embolism, stating that in more than 80 percent of patients with acute pulmonary embolism, echocardiography reveals abnormalities. However, others report that most patients with pulmonary embolism have normal echocardiographic results.2 For that reason, echocardiography has not been recommended as a routine imaging test for the diagnosis of suspected pulmonary embolism.3


Ariel Jaitovich, M.D.
Northwestern University
Chicago, IL 60611
a-jaitovich{at}northwestern.edu

References

  1. Farzaneh-Far R, Schwarzberg T, Mushlin SB. Thinking outside the box. N Engl J Med 2006;354:2376-2381. [Free Full Text]
  2. Goldhaber SZ. Pulmonary embolism. N Engl J Med 1998;339:93-104. [Free Full Text]
  3. Goldhaber SZ. Echocardiography in the management of pulmonary embolism. Ann Intern Med 2002;136:691-700. [Free Full Text]
 
To the Editor: Farzaneh-Far et al. state that "although this is the patient's first thromboembolic event, testing him for a hypercoagulable state would be reasonable." This statement requires clarification.

There is currently no consensus regarding whom to test for the inherited thrombophilias. Each year, approximately 250,000 patients receive a diagnosis of acute venous thromboembolism. It has been argued that testing of all patients with an initial episode of venous thromboembolism is not cost-effective.1 For patients with an initial episode of idiopathic venous thromboembolism, routine testing for an inherited thrombophilic defect would only be warranted if the results changed the treatment approach. However, Farzaneh-Far et al. later state that they "favor providing long-term anticoagulation with warfarin." If the decision has already been made to provide long-term anticoagulation, then the clinical utility of testing for a hypercoagulable state is limited.


Marc Itskowitz, M.D.
Allegheny General Hospital
Pittsburgh, PA 15212
mitskowi{at}wpahs.org

References

  1. Murin S, Marelich GP, Arroliga AC, Matthay RA. Hereditary thrombophilia and venous thromboembolism. Am J Respir Crit Care Med 1998;158:1369-1373. [Free Full Text]
 
The authors reply: Dr. Jaitovich correctly points out that many patients with pulmonary embolism do not have echocardiographic abnormalities; we wish to clarify that the high rate of echocardiographic abnormalities we noted would apply to patients with massive pulmonary embolism. Nevertheless, echocardiographic evidence of right ventricular dysfunction in patients with unexplained hemodynamic instability can suggest the diagnosis of pulmonary embolism and may warrant further diagnostic testing by spiral computed tomography of the chest with intravenous contrast.1 The primary role of echocardiography in acute pulmonary embolism is risk stratification. As we noted in our commentary, right ventricular hypokinesis is a powerful independent predictor of 90-day mortality in patients with submassive pulmonary embolism (defined as a systolic arterial pressure greater than 90 mm Hg).2

Dr. Itskowitz makes an important point regarding the lack of consensus about indications for testing for inherited thrombophilias. We agree that routine testing of all patients with idiopathic venous thromboembolism is not cost-effective. However, one could argue that a patient who has an idiopathic venous thromboembolism before 50 years of age has thrombophilia, and therefore, laboratory investigation is warranted.3 Given that abnormalities predisposing patients to venous thromboembolism, including protein S deficiency, are more common in patients with HIV infection, testing a 35-year-old man with HIV is not unreasonable, albeit costly. Although long-term anticoagulation was favored in this patient regardless of the test results, because of the life-threatening nature of his pulmonary embolism, such results could influence the intensity of anticoagulation. If the patient were found to have clinically significant titers of antiphospholipid antibodies, for example, his target international normalized ratio might be higher than that of a patient without this finding.


Ramin Farzaneh-Far, M.D.
University of California, San Francisco
San Francisco, CA 94117


Talya Schwarzberg, M.D.
Beth Israel Deaconess Medical Center
Boston, MA 02215
tschwar1{at}bidmc.harvard.edu

References

  1. Goldhaber SZ. Echocardiography in the management of pulmonary embolism. Ann Intern Med 2002;136:691-700. [Free Full Text]
  2. Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med 2005;165:1777-1781. [Free Full Text]
  3. Kitchens CS, Alving BM, Kessler CM, eds. Consultative hemostasis and thrombosis. Philadelphia: W.B. Saunders, 2002.

 

This Article
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Farzaneh-Far, R.
-PubMed Citation

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.